C3 and Alzheimer disease: In the correlation analyses, serum complement C3 level was negatively related to CSF t‐tau protein in APOE ε4+ AD group, which may be supported by a proposed theory suggesting that APOE ε4 may have effects on the involvement of complement C3 in the amplification of pathological processes in the AD brain [11].